Project/Area Number |
25860088
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Drug development chemistry
|
Research Institution | Tohoku Pharmaceutical University |
Principal Investigator |
|
Co-Investigator(Renkei-kenkyūsha) |
TAKAHATA Hiroki 東北薬科大学, 薬学部, 教授 (00109109)
YOSHIMURA Yuichi 東北薬科大学, 薬学部, 教授 (00230813)
KATO Atsushi 富山大学, 付属病院薬剤部, 准教授 (60303236)
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2013: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | 医薬品化学 / イミノ糖 / 医薬分子設計 / 酵素阻害活性物質 / α-グルコシダーゼ阻害薬 / ゴーシェ病治療薬 / ケミカルシャペロン療法 / イミノ糖誘導体 / ライソゾーム病 / 化学シャペロン療法 / 構造活性相関研究 |
Outline of Final Research Achievements |
This research program aimed at developing new potent and selective glucosidase inhibitors. I have focused on the α-1-C-substituted L- and D- iminofuranose derivatives.The asymmetric syntheses of α-1-C-alkyl D- and L-iminofuranose derivatives were achieved. Their inhibitory activities were measured.
|